# Low Doses Corticosteroids as Adjuvant Therapy for the Treatment of Severe H1N1 Flu

> **NCT01014364** · PHASE3 · TERMINATED · sponsor: **University of Versailles** · enrollment: 40 (actual)

## Conditions studied

- Pneumonia, Viral
- Influenza in Humans

## Interventions

- **DRUG:** hydrocortisone
- **DRUG:** isotonic saline

## Key facts

- **NCT ID:** NCT01014364
- **Lead sponsor:** University of Versailles
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-03
- **Primary completion:** 2011-06
- **Final completion:** 2011-12
- **Target enrollment:** 40 (ACTUAL)
- **Why stopped:** the H1N1 pandemic is now over, and fewer cases than expected were observed
- **Last updated:** 2014-12-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01014364

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01014364, "Low Doses Corticosteroids as Adjuvant Therapy for the Treatment of Severe H1N1 Flu". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01014364. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*